Intraperitoneal Delivery of Adaptive Natural Killer (NK) Cells (FATE-NK100) With Intraperitoneal Int
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Fallopian Tube Cancer
Related studies linked through entity extraction aliases.
Collection of Malignant Ascites, Pleural Fluid, and Blood From People With Solid Tumors
- Status
- TERMINATED
- Phase
- N/A
Vinorelbine in Relapsed Platinum Resistant or Refractory C5 High Grade Serous, Endometrioid, or Undifferentiated Primary Peritoneum, Fallopian Tube or Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Efficacy of HIPEC as NACT and Postoperative Chemotherapy in the Treatment of Advanced-Stage Epithelial Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Homologous Recombination Inquiry Through Ovarian Malignancy Investigations
- Status
- COMPLETED
- Phase
- N/A
Biomarkers for Early Detection of Ovarian Cancer Using Uterine Lavage
- Status
- UNKNOWN
- Phase
- NA
Neo-adjuvant Pembrolizumab in Primary Stage IV Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Evaluation of Weekly Ixabepilone With or Without Biweekly Bevacizumab
- Status
- COMPLETED
- Phase
- PHASE2
Ribociclib (Ribociclib (LEE-011)) With Platinum-based Chemotherapy in Recurrent Platinum Sensitive Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
CAR T Cells in Mesothelin Expressing Cancers
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life
- Status
- UNKNOWN
- Phase
- N/A
Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer
- Status
- COMPLETED
- Phase
- N/A
Intraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Factors Associated With the Use of a High Volume Cancer Center by Black Women With Ovarian Cancer: A Qualitative Study
- Status
- COMPLETED
- Phase
- N/A
Study of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Bevacizumab in Ovarian Cancer Patients With Disease at Second-Look Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pembrolizumab Combined With PLD For Recurrent Platinum Resistant Ovarian, Fallopian Tube Or Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2